Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5 Neoplasms 3 Uterine Neoplasms 1 Stomach Neoplasms 1 Obesity 1 Motor Activity 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Cardiotoxicity 1

Interventions

Gemcitabine 39 Cisplatin 24 Oxaliplatin 15 pembrolizumab 12 Capecitabine 12 Fluorouracil 9 Leucovorin 7 Albumin-Bound Paclitaxel 7 lenvatinib 6 Radiofrequency Ablation 6 Panitumumab 6 130-nm albumin-bound paclitaxel 6 Irinotecan 5 Bevacizumab 5 durvalumab 4 Taxes 4 Nivolumab 4 Hepatectomy 4 Drug Therapy 4 tremelimumab 3 apatinib 3 Radiosurgery 3 Platinum 3 Injections 3 Floxuridine 3 Cetuximab 3 1,2-diaminocyclohexaneplatinum II citrate 3 trametinib 2 spartalizumab 2 sintilimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cholangiocarcinoma × Biomarkers × Clear all

NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡